Loading
Latest filing published 02 May 2023 for Cassava Sciences INC, €33k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Robert Z. Gussin on record concern Filana Therapeutics, Inc., in the capacity of board member. In total, 3 filings cover trades dated from 15 September 2021 to 1 May 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 2 May 2023 with an option exercise (€33k) in Filana Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations